Table 4.
RR, response rate; PFS, progression-free survival; TTP, time-to-progression; OS, overall survival; GEM, gemcitabine; CDDP, cisplatin; FAM, 5-fluorouracil + doxorubicin + mitomycin-C.
RR, response rate; PFS, progression-free survival; TTP, time-to-progression; OS, overall survival; GEM, gemcitabine; CDDP, cisplatin; FAM, 5-fluorouracil + doxorubicin + mitomycin-C.